Morgan Stanley’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.78M Buy
703,940
+85,555
+14% +$1.17M ﹤0.01% 3583
2025
Q4
$8.53M Buy
618,385
+122,750
+25% +$2.89M ﹤0.01% 3741
2025
Q3
$12.1M Buy
495,635
+179,904
+57% +$4.38M ﹤0.01% 3373
2025
Q2
$7.29M Buy
315,731
+33,304
+12% +$878K ﹤0.01% 3740
2025
Q1
$7.63M Buy
282,427
+64,596
+30% +$2.43M ﹤0.01% 3572
2024
Q4
$11.7M Buy
217,831
+77,367
+55% +$4.09M ﹤0.01% 3282
2024
Q3
$6.38M Buy
140,464
+58,666
+72% +$2.55M ﹤0.01% 3778
2024
Q2
$3.43M Sell
81,798
-39,433
-33% -$1.85M ﹤0.01% 4187
2024
Q1
$4.56M Sell
121,231
-13,665
-10% -$298K ﹤0.01% 3980
2023
Q4
$1.45M Buy
134,896
+114,440
+559% +$990K ﹤0.01% 5122
2023
Q3
$206K Buy
20,456
+1,975
+11% +$22.8K ﹤0.01% 5563
2023
Q2
$219K Sell
18,481
-15,023
-45% -$201K ﹤0.01% 5612
2023
Q1
$405K Buy
33,504
+16,020
+92% +$267K ﹤0.01% 5371
2022
Q4
$230K Sell
17,484
-123,996
-88% -$1.81M ﹤0.01% 5607
2022
Q3
$1.92M Buy
141,480
+113,747
+410% +$1.52M ﹤0.01% 4461
2022
Q2
$337K Sell
27,733
-10
-0% -$118 ﹤0.01% 5621
2022
Q1
$398K Buy
27,743
+13,264
+92% +$217K ﹤0.01% 5534
2021
Q4
$285K Buy
14,479
+7,777
+116% +$163K ﹤0.01% 5874
2021
Q3
$145K Buy
6,702
+6,602
+6,602% +$190K ﹤0.01% 6170
2021
Q2
$2K Buy
+100
New +$2.23K ﹤0.01% 7526

Other funds holding JANX